Tenax Therapeutics Inc news

   Watch this stock
Showing stories 1 - 10 of about 81   

Articles published

TENX 3.26 +0.12 (3.82%)
price chart
Tenax Therapeutics Announces Analyst Day and Webcast on April 13, 2015
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced that the company will ...
Oxygen Biotherapeutics Announces Name Change to Tenax Therapeutics
MORRISVILLE, N.C., Sep 16, 2014 (BUSINESS WIRE) -- Oxygen Biotherapeutics, Inc. OXBT a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced that the ...
Beleagured Morrisville drug developer changes name, sharpens focus  Triangle Business Journal
Related articles »  
Tenax Therapeutics' (TENX) CEO John Kelley on Q2 2015 Results - Earnings ...
Tenax Therapeutics' (TENX) CEO John Kelley on Q2 2015 Results - Earnings Call Transcript. Dec. 17, 2014 1:19 PM ET | About: Tenax Therapeutics, Inc. (TENX) by: SA Transcripts. Tenax Therapeutics Inc. (NASDAQ:TENX). Q2 2015 Earnings Conference ...
Tenax Therapeutics Announces Second Quarter Fiscal Year 2015 Financial ...  MarketWatch
Related articles »  
Tenax Therapeutics to Present at Cowen & Company 35th Annual Health Care ...
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, announced today that John Kelley, ...
Tenax Therapeutics to Provide Corporate Update and Discuss Third Quarter ...
Tenax Therapeutics, Inc. (formerly Oxygen Biotherapeutics) is a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market.
Tenax Therapeutics Inc.: Tenax Therapeutics to Provide Corporate Update and ...  The Wall Street Transcript
Tenax Therapeutics Announces Third Quarter Fiscal Year 2015 Financial Results
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced financial results for ...
Tenax Therapeutics (TENX) Releases Earnings Results, Beats Expectations By ...  The Legacy
Achillion Pharmaceuticals Inc (ACHN), Tenax Therapeutics Inc (TENX): Peter ...
As a result, RA Capital Management is left holding 8.03 million shares of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN). In another move, the fund's manager, Peter Kolchinsky, has initiated a position in Tenax Therapeutics Inc (NASDAQ:TENX). According ...
Related articles »  
Mid-Day Changers: O2Micro International Ltd. (OIIM), Tenax Therapeutics, Inc ...
O2Micro International Ltd. (OIIM) of the Technology sector has changed by 3.19% and at noon is trading with a volume of 2,000 shares with a volatility this week of 3.20%.
Tenax Therapeutics Announces First Quarter Fiscal Year 2015 Financial Results
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), formerly Oxygen Biotherapeutics, Inc., a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, ...
Tenax Therapeutics' (TENX) CEO John Kelley on Q1 2015 Results - Earnings ...  Seeking Alpha (registration)
Related articles »  
Tenax Therapeutics Announces First Patients Enrolled in Phase 3 LEVO-CTS ...
Tenax Therapeutics, Inc. (formerly Oxygen Biotherapeutics) is a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market.
Morrisville's Tenax studies experimental drug in cardiac surgery patients  Triangle Business Journal
Related articles »